Inventions shaping technological trajectories: Do existing patent indicators provide a comprehensive picture?

Scientometrics

Volumn 97, Issue 2, 2013, Pages 397-419

  Arts, Sam ^a,b   Appio, Francesco Paolo ^c   Van Looy, Bart ^a,d,e  

^a Managerial Economics and Strategy Group   (Belgium)

^b RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

^d Katholieke Universiteit Leuven   (Belgium)

^e UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Biotechnology; Important technological inventions; Patent indicators; Validation

Indexed keywords

EID: 84885841814     PISSN: 01389130     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11192-013-1045-1     Document Type: Article

References (43)

1. Ahuja, G., & Lampert, C. M. (2001). Entrepreneurship in the large corporation: A longitudinal study of how established firms create breakthrough inventions. Strategic Management Journal, 22, 521-543.
2. Albert, M. B., Avery, D., Narin, F., & McAllister, P. (1991). Direct validation of citation counts as indicators of industrially important patents. Research Policy, 20(3), 251-259.
3. Arts, S. (2012). Path dependency and recombinant exploration: How established firms can outperform in the creation of technological breakthroughs. FEB Research Report MSI_1228.
4. Basalla, G. (1988). The evolution of technology. Cambridge, MA: Cambridge University Press.
5. Buchholz, K., & Collins, J. (2010). Concepts in biotechnology history, science and business. Weinheim: Wiley, VCH.
6. Bud, R. (1993). The uses of life: A history of biotechnology. Cambridge, MA: Cambridge University Press.
7. Carpenter, M., & Narin, F. (1993). Validation study: Patent citations as indicators of science and foreign dependence. World Patent Information, 5(3), 180-185.
8. Chandy, R. K., & Tellis, G. J. (2000). The incumbent's curse? Incumbency, size, and radical product innovation. The Journal of Marketing, 64(3), 1-17.
9. Christensen, C. (2003). The Innovator's Solution. Cambridge: Harvard Business School Press.
10. Cohen, S., & Boyer, H. (1979/1980). Process for producing biologically functional molecular chimeras. US Patent 4, 237, 224.
11. Cohen, S., Chang, A. C. Y., & Hsu, L. (1972). Nonchromosomal antibiotic resistance in bacteria: Genetic transformation of E. coli by R-factor DNA. Proceedings of the National Academy of Sciences of the United States of America, 69, 2110-2114.
12. Dahlin, K. B., & Behrens, D. M. (2005). When is an invention really radical?: Defining and measuring technological radicalness. Research Policy, 34(5), 717-737.
13. Dosi, G. (1982). Technological paradigms and technological trajectories: A suggested interpretation of the determinants and directions of technical change. Research Policy, 11, 147-162.
14. Fleming, L. (2001). Recombinant uncertainty in technology search. Management Science, 47(1), 117-132.
15. Fleming, L., Mingo, S., & Chen, D. (2007). Collaborative brokerage, generative creativity and creative success. Administrative Science Quarterly, 52(3), 443-475.
16. Freeman, C. (1992). The economics of hope. New York: Pinter Publishers.
17. Gambardella, A., Harhoff, D., & Verspagen, B. (2008). The value of European patents. European Management Review, 5(2), 69-84.
18. Griliches, Z. (1984). R&D, patents, and productivity. Chicago: University of Chicago Press.
19. Hall, B. H., Jaffe, A. B., & Trajtenberg, M. (2001). The NBER patent citation data file: Lessons, insights and methodological tools. NBER Working Paper 8498.
20. Hall, B. H., Jaffe, A. B., & Trajtenberg, M. (2005). Market value and patent citations. RAND Journal of Economics, 36(1), 16-38.
21. Harhoff, D., Narin, F., Scherer, F., & Vopel, K. (1999). Citation frequency and the value of patented inventions. The Review of Economics and Statistics, 81(3), 511-515.
22. Henderson, R. (1993). Underinvestment and incompetence as responses to radical innovation-evidence from the photolithographic alignment equipment industry. RAND Journal of Economics, 24(2), 248-270.
23. Henderson, R. M., & Clark, K. B. (1990). Architectural innovation: The reconfiguration of existing product technologies and the failure of established firms. Administrative Science Quarterly, 35(1), 9-30.
24. Hotchkiss, R. D. (1979). The identification of nucleic acids as genetic determinants. In P. R. Srinivasan, J. S. Fruton, & J. T. Edsall (Eds.), The origins of modern biochemistry. New York: New York Academy of Sciences.
25. Jaffe, A., & Trajtenberg, M. (2002). Patents, citations and innovations. Boston, MA: MIT Press.
26. Jaffe, A., Trajtenberg, M., & Fogarty, M. S. (2000). The meaning of patent citations: Report on the NBER/case-western reserve survey of patentees. NBER Working Paper No. W7631.
27. Kaplan, S., & Vakili, K. (2012). Breakthrough innovations: Using topic modeling to distinguish the cognitive from the economic: Academy of Management Best Paper Proceedings.
28. Keener, K., Hoban, T., & Balasubramanian, R. (2012). Biotechnology and its Applications. Retrieved February 22, 2012 from http://www. ces. ncsu. edu/depts/foodsci/ext/pubs/bioapp. pdf.
29. Magerman, T., van Looy, B., & Song, X. (2010). Exploring the feasibility and accuracy of latent semantic analysis based text mining techniques to detect similarity between patent documents and scientific publications. Scientometrics, 82(2), 289-306.
30. McGloughlin, M. N., & Re, B. E. (2010). The evolution of biotechnology. From Natufians to nanotechnology. Dordrecht: Springer.
31. Nelson, R., & Winter, S. (1982). An evolutionary theory of economic change. Cambridge: Belknap Press.
32. OECD. (2005). A framework for Biotechnology Statistics.
33. Reuss, M. (2001). Editorial. Bioprocess and Biosystems Engineering, 24(1), 1.
34. Scherer, F. M., & Harhoff, D. (2000). Policy implications for a world with skew-distributed returns to innovation. Research Policy, 29(4), 559-566.
35. Schumpeter, J. (1934). The theory of economic development. Cambridge, MA: Harvard University Press.
36. Singh, J., & Fleming, L. (2010). Lone Inventors as Sources of Breakthroughs: Myth or Reality? Management Science, 56(1), 41-56.
37. Sinskey, A. J. (1999). Foreword. Metabolic Engineering, 1(3), 3-5.
38. Stephanopoulos, G. (1999). Metabolic fluxes and metabolic engineering. Metabolic Engineering, 1(1), 1-11.
39. Trajtenberg, M. (1990). A penny for your quotes: Patent citations and the value of innovations. RAND Journal of Economics, 21(1), 172-187.
40. Trajtenberg, M., Jaffe, A., & Henderson, R. (1997). University versus corporate patents: A window on the basicness of invention. Economics of Innovation and New Technology, 5(1), 19-50.
41. Tushman, M. L., & Anderson, P. (1986). Technological discontinuities and organizational environments. Administrative Science Quarterly, 31(3), 439-465.
42. Utterback, J. M. (1994). Mastering the dynamics of innovation: How companies can seize opportunities in the face of technological change. Boston: Harvard Business School Press.
43. Watson, J. D., & Crick, F. H. C. (1953). The structure of DNA. Cold Spring Harbor Symposia on Quantitative Biology, 18, 123-131.